Premier Stocks League

These dow jones stocks are moving in today's session 🔗

Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Tue...

S&P 500 biggest August 2026 winners: Moderna, software stocks 🔗

Moderna stock led the index after melanoma vaccine data, while a hedge fund's forced unwind turbocharged a rebound in enterprise software

Why Novartis Stock Is Heading for Its Best Day Since 2023 After 3 Patient Deaths 🔗

Novartis says it has paused clinical trials for rap-cel in patients with autoimmune disease, while reporting positive data for a different potential b...

Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy 🔗

Merck KGaA (NYSE:MRK) shares rose 1. 7% to €141.

4 Reasons Why SCHD May Be In A Trouble (Rating Downgrade) 🔗

Exelixis: "Hold" On Zanzalintinib Subpopulation Miss And STELLAR-304 2H 2026 Data 🔗

Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell? 🔗

The company may be on track to its next product.

Moderna (MRNA) Soars 156% in August — Here’s What Propelled The Rally 🔗

Moderna Inc. (NASDAQ:MRNA) saw its share price soar by 156 percent in August—making it the highest-gaining stock for the month—driven primarily by...

There Was No Beating Moderna in August. These Are the Best and Worst S&P 500 Stocks for the Month. 🔗

Moderna stock surged 158% in August to lead the S&P 500, while Edison International plunged 27% to rank last in the index.

Top dow jones movers in Monday's session 🔗

Get insights into the dow jones index performance on Monday. Explore the top gainers and losers within the dow jones index in today's session.

UBS Michael Yee: We've been quite bullish on the pharma sector 🔗

Michael Yee, UBS, joins 'Closing Bell Overtime' to talk the state of the biotech and pharmaceutical sectors.

From Padcev to PF-08634404: Pfizer's Oncology Growth Push 🔗

PFE's oncology growth is led by Padcev, while a broad pipeline and label expansions aim to fuel longer-term gains.

Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know 🔗

Nomura Value Fund Q2 2026 Portfolio Activity 🔗

After outperforming its benchmark in 1Q2026, the Nomura Value Fund Institutional Class shares lost considerable ground to the Russell 1000® Value I...

Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs 🔗

Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...

Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging 🔗

August has been a great month for the shares of Merck & Co., Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), to say the least. The former’s stoc...

SCHD Is Up Nearly 30% and Its Yield Is Back Near 3% | Did Dividend Investors Miss the Easy Money? 🔗

SCHD just delivered a return most dividend investors spend a decade waiting for, and that success created a problem nobody predicted. Whether fresh mo...

Is Merck Stock Outperforming the Nasdaq? 🔗

Merck has surged past the broader Nasdaq Composite over the past year, and analysts remain somewhat optimistic about the stock’s growth potential.

Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma Therapy 🔗

Merck (NYSE:MRK) and Moderna report the first positive Phase 3 results for an individualized mRNA neoantigen cancer therapy in melanoma patients. The ...

Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial 🔗

The health-care sector was on track for its strongest week since June 26, with the Health Care index rising more than 4% in the five trading days lead...

Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial 🔗

On the August 26 episode of Mad Money, a caller mentioned that they had purchased 1,000 shares of Moderna, Inc. (NASDAQ:MRNA) at $54 a couple of weeks...

Did A Product Swap Fuel JNJ Stock’s 54% Surge? 🔗

The signs were not in the headline growth rate but in which two products were trading places.

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win 🔗

BioNTech says it’s ending a Phase 2 trial for its investigational personalized mRNA cancer vaccine. It was being tested to treat colorectal cancer.

Can Merck Stock Outrun Its Pipeline? 🔗

Revenue grew at its usual pace over the past year while the stock outran its biggest peers, and the gap sits in a run of clinical readouts that landed...

What's going on in today's session: dow jones movers 🔗

Get insights into the dow jones index performance on Friday. Explore the top gainers and losers within the dow jones index in today's session.

BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall 🔗

BioNTech (BNTX) shares slumped Friday after the company said it is terminating a mid-stage clinical

BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’ 🔗

BioNTech said on Friday that it and its partner, Genentech, a Roche unit, are ending the mid-stage study of autogene cevumeran, used alone after surge...

Stay informed with the top movers within the dow jones index on Friday. 🔗

Join us in exploring the top gainers and losers within the dow jones index in the middle of the day on Friday as we examine the latest happenings in t...

World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency 🔗

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democr...

What's going on in today's after hours session: S&P500 movers 🔗

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable S&P500...

Stay updated with the stocks that are on the move in today's after-hours session. 🔗

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours ses...

Thursday's session: top gainers and losers in the dow jones index 🔗

Stay updated with the movement of dow jones stocks in today's session. Discover which dow jones stocks are making waves on Thursday.